Cargando…

Urinary Galectin-3 as a Novel Biomarker for the Prediction of Renal Fibrosis and Kidney Disease Progression

Plasma galectin-3 (Gal-3) is associated with organ fibrosis, but whether urinary Gal-3 is a potential biomarker of kidney disease progression has never been explored. Between 2018 and 2021, we prospectively enrolled 280 patients who underwent renal biopsy and were divided into three groups based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ou, Shuo-Ming, Tsai, Ming-Tsun, Chen, Huan-Yuan, Li, Fu-An, Lee, Kuo-Hua, Tseng, Wei-Cheng, Chang, Fu-Pang, Lin, Yao-Ping, Yang, Ruey-Bing, Tarng, Der-Cherng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945118/ https://www.ncbi.nlm.nih.gov/pubmed/35327386 http://dx.doi.org/10.3390/biomedicines10030585

Ejemplares similares

Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy
por: Ou, Shuo-Ming, et al.
Publicado: (2021)

Relationship between Circulating Galectin-3, Systemic Inflammation, and Protein-Energy Wasting in Chronic Hemodialysis Patients
por: Tsai, Ming-Tsun, et al.
Publicado: (2021)

Sepsis and the Risks of Long-Term Renal Adverse Outcomes in Patients With Chronic Kidney Disease
por: Ou, Shuo-Ming, et al.
Publicado: (2022)

Artificial Intelligence for Risk Prediction of End-Stage Renal Disease in Sepsis Survivors with Chronic Kidney Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2022)

Artificial Intelligence for Risk Prediction of Rehospitalization with Acute Kidney Injury in Sepsis Survivors
por: Ou, Shuo-Ming, et al.
Publicado: (2022)

Trichostatin A Alleviates Renal Interstitial Fibrosis Through Modulation of the M2 Macrophage Subpopulation
por: Tseng, Wei-Cheng, et al.
Publicado: (2020)

Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Beyond a Measure of Liver Function—Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients
por: Tsai, Ming-Tsun, et al.
Publicado: (2018)

Comparison of Simplified Creatinine Index and Systemic Inflammatory Markers for Nutritional Evaluation of Hemodialysis Patients
por: Tsai, Ming-Tsun, et al.
Publicado: (2021)

Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy
por: Tseng, Wei-Cheng, et al.
Publicado: (2021)

Echocardiographic features of left ventricular dysfunction and outcomes in chronic kidney disease
por: Ou, Shuo-Ming, et al.
Publicado: (2023)

AN69 Filter Membranes with High Ultrafiltration Rates during Continuous Venovenous Hemofiltration Reduce Mortality in Patients with Sepsis-Induced Multiorgan Dysfunction Syndrome
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Prediction of the risk of developing end-stage renal diseases in newly diagnosed type 2 diabetes mellitus using artificial intelligence algorithms
por: Ou, Shuo-Ming, et al.
Publicado: (2023)

Urinary Calculi and Risk of Cancer: A Nationwide Population-Based Study
por: Shih, Chia-Jen, et al.
Publicado: (2014)

The impact of dialysis therapy on older patients with advanced chronic kidney disease: a nationwide population-based study
por: Shih, Chia-Jen, et al.
Publicado: (2014)

Hyperuricemia Predicts an Early Decline in Renal Function among Older People: A Community-Based Cohort Study
por: Tseng, Wei-Cheng, et al.
Publicado: (2019)

U‐Shaped Association Between Serum Uric Acid Levels With Cardiovascular and All‐Cause Mortality in the Elderly: The Role of Malnourishment
por: Tseng, Wei‐Cheng, et al.
Publicado: (2018)

Association of Anemia and Iron Parameters With Mortality Among Patients Undergoing Prevalent Hemodialysis in Taiwan: The AIM‐HD Study
por: Kuo, Ko‐Lin, et al.
Publicado: (2018)

Trajectory of Estimated Glomerular Filtration Rate and Malnourishment Predict Mortality and Kidney Failure in Older Adults With Chronic Kidney Disease
por: Weng, Shuo-Chun, et al.
Publicado: (2021)

The Anti-Inflammatory, Anti-Oxidative, and Anti-Apoptotic Benefits of Stem Cells in Acute Ischemic Kidney Injury
por: Lee, Kuo-Hua, et al.
Publicado: (2019)

Expression of decoy receptor 3 in kidneys is associated with allograft survival after kidney transplant rejection
por: Weng, Shuo-Chun, et al.
Publicado: (2015)

Impact of physical activity on the association between lipid profiles and mortality among older people
por: Ou, Shuo-Ming, et al.
Publicado: (2017)

Timing of kidney biopsy in type 2 diabetic patients: a stepwise approach
por: Hsieh, Jyh-Tong, et al.
Publicado: (2020)

Iron Therapy in Chronic Kidney Disease: Days of Future Past
por: Lee, Kuo-Hua, et al.
Publicado: (2021)

Association of Hypoglycemia With Incident Chronic Kidney Disease in Patients With Type 2 Diabetes: A Nationwide Population-Based Study
por: Shih, Chia-Jen, et al.
Publicado: (2015)

Associations of the Serum Total Carbon Dioxide Level with Long-Term Clinical Outcomes in Sepsis Survivors
por: Yang, Ching Han, et al.
Publicado: (2023)

Dipyridamole decreases dialysis risk and improves survival in patients with pre-dialysis advanced chronic kidney disease
por: Kuo, Ko-Lin, et al.
Publicado: (2017)

UMOD Mutations in Chronic Kidney Disease in Taiwan
por: Chen, Huan-Da, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease
por: Li, Szu-Yuan, et al.
Publicado: (2020)

The Role of Galectin-3 in the Kidneys
por: Chen, Szu-Chia, et al.
Publicado: (2016)

Increased circulating galectin-1 levels are associated with the progression of kidney function decline in patients undergoing coronary angiography
por: Kuo, Chin-Sung, et al.
Publicado: (2020)

Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease
por: Wu, Chia-Lin, et al.
Publicado: (2020)

Role of galectins in lung cancer
por: Chang, Wei-An, et al.
Publicado: (2017)

Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
por: Hung, Szu‐Chun, et al.
Publicado: (2017)

Granulocyte Colony-Stimulating Factor Improves Endothelial Progenitor Cell-Mediated Neovascularization in Mice with Chronic Kidney Disease
por: Tang, Shao-Yu, et al.
Publicado: (2023)

Volume Overload and Adverse Outcomes in Chronic Kidney Disease: Clinical Observational and Animal Studies
por: Hung, Szu-Chun, et al.
Publicado: (2015)

Estimated Glomerular Filtration Rate Decline Is a Better Risk Factor for Outcomes of Systemic Disease-Related Nephropathy than for Outcomes of Primary Renal Diseases
por: Weng, Shuo-Chun, et al.
Publicado: (2014)

Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis
por: Yang, Chih-Yu, et al.
Publicado: (2017)

Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade
por: Lin, Chih-Ching, et al.
Publicado: (2017)

Migraine and subsequent chronic kidney disease risk: a nationwide population-based cohort study
por: Weng, Shuo-Chun, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uvbo6t9igvtk13qrvnhasu70ss